Research

The National Science Foundation has issued its first-ever awards for the NSF INCLUDES program, a comprehensive initiative to enhance U.S. leadership in science and engineering by broadening participation in STEM fields. Principal investigator Maithilee Kunda and co-P.I. Kelly Holley-Bockelmann are among the recipients. Read More

New ethical rules for scientists who do experiments involving human beings are about to kick in. It's the first update in more than 40 years. Read More

Emerging viral infections like Zika keep popping up around the world in such quick succession that medicine is having a hard time keeping up. It can take 15 years and more than a billion dollars to bring a new drug to market. Read More

Stanford University's Sean Reardon will discuss results from his new study, which analyzed racial and ethnic achievement gaps in several hundred metropolitan areas and several thousand school districts in the United States. Read More

How many heart transplant programs do we really need? That was a question posed by a group of investigators, including Vanderbilt University Medical Center’s Ashish Shah, M.D., in a novel study that used a computerized algorithm to highlight the value of high-volume transplant centers with corresponding improved outcomes. Read More

Researchers at Vanderbilt University Medical Center have discovered a key mechanism that explains how compounds they’re developing can suppress schizophrenia-like symptoms without side effects in mice. Read More

A research team led by structural biologists from Vanderbilt University has come up with the first detailed molecular explanation for a factor that may contribute to the so-called cystic fibrosis (CF) “gender gap.” Read More

A model of honeybee behavior developed by a VU alum, now adapted to control internet server traffic, won an award honoring obscure or odd-seeming research that led to an important advance. Read More

The University Council for Educational Administration has selected Vanderbilt researcher Ellen Goldring to receive its prestigious Roald F. Campbell Lifetime Achievement Award for 2016. Read More

Modulation of T cell metabolism thus may represent a new therapeutic avenue for leukemia patients. Read More

High levels of blood markers for vascular endothelial dysfunction were associated with longer periods of confusion in ICU patients, Vanderbilt researchers have discovered. Read More

Vanderbilt's Study of Mathematically Precocious Youth is featured in the September issue of the prestigious scientific journal "Nature." Read More

Vanderbilt researchers developed a new algorithm to find clinically targetable gene rearrangements in cancers. Read More

A multi-center research team including scientists from the Vanderbilt Vaccine Center has come up with a clever “Trojan Horse” strategy for thwarting the highly lethal Ebola virus. Read More

A protein called Gremlin 2 controls the extent of inflammation after heart attack and may be a good therapeutic target. Read More

Odd of foreclosure were 42 percent lower among those who completed the homebuyer class. Read More

William Tansey, Ph.D., professor of Cell Development and Biology and Ingram Professor of Cancer Research, has been awarded a two-year, $250,000 grant from Alex’s Lemonade Stand Foundation (ALSF) to study malignant rhabdoid tumors (MRTs). Read More

A consortium led by Vanderbilt University Medical Center (VUMC) researchers has received funding as it makes plans for a multicenter trial that could determine whether deep brain stimulation (DBS) slows the progression of Parkinson’s disease in early-stage patients. Read More

Researchers at Vanderbilt University Medical Center and Vanderbilt University have received a $1.9 million grant from the National Institutes of Health (NIH) to support research to restore vision through regeneration of the retina. Read More

The sphere-forming frequency of neuroblastoma cells is a measure of their proliferative capacity and could help guide treatment strategies for neuroblastoma. Read More